In this activity, an expert in mood disorders discusses differentiation of bipolar disorder and major depressive disorder.
Upon completion of this activity, participants should be better able to:
This activity has been designed to meet the educational needs of primary care physicians and other clinicians involved in the treatment of mood disorders.
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
In accordance with ACCME requirements, the Semel Institute for Neuroscience and Human Behavior at UCLA and the Institute for Medical Education, have a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.
Michael J. Gitlin, MD Professor of Clinical Psychiatry Director, Mood Disorders Clinic Medical Director, Department of Psychiatry Neuropsychiatric Behavioral Health Services Director, Adult Division UCLA Department of Psychiatry UCLA Psychiatric Hospital Los Angeles, California
Michael J. Gitlin, MD, has a financial interest/relationship or affiliation in the form of: Speakers Bureau participant with AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; and Eli Lilly and Company.
Franklin David Rudnick, MD Staff Psychiatrist St. John's Medical Center Santa Monica, California
Franklin David Rudnick, MD, currently has no financial interests/relationships or affiliations in relation to this activity.
Annette Wiggins PVI, PeerView Institute for Medical Education, Inc.
Annette Wiggins currently has no financial interests/relationships or affiliations in relation to this activity.
This program was developed and reviewed by faculty members of the David Geffen School of Medicine at UCLA. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Institute for Medical Education and the Semel Institute for Neuroscience and Human Behavior at UCLA, in association with PVI, PeerView Institute for Medical Education. The Institute for Medical Education takes responsibility for the content, quality and scientific integrity of this CME activity.
The Institute for Medical Education designates this educational activity for a maximum of 1.0 hour of AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
This CME activity is sponsored by the Semel Institute for Neuroscience and Human Behavior at UCLA and the Institute for Medical Education, in association with PVI, PeerView Institute for Medical Education.
This activity is supported by educational grants from
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
All contents copyright © 2000-, PeerView Press. All rights reserved.
